Avid Bioservices announces closing of public offering of common stock
Avid Bioservices announced the closing of its previously announced underwritten public offering of 10,294,445 shares of its common stock, including 1,294,445 shares sold pursuant to the underwriters' exercise of their option to purchase additional shares. Gross proceeds were $23,162,501. February 20, 2018